Dopamine agonists for pituitary tumours: to treat or not?

The benefits and risks of giving patients medical therapy after surgery to prevent regrowth of nonfunctioning pituitary adenomas was debated at the European Congress of Endocrinology 2017, with the final vote revealing a 50-50 split of opinion from the audience.Medscape
Source: Society for Endocrinology - Category: Endocrinology Source Type: news